Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor

NCT00694330 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

BIOLOGICAL: GM-K562 Vaccination

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]